National Underuse of Anti-Thrombotic Therapy in Chronic Atrial Fibrillation Identified From Digoxin Prescribing

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/j.1365-2125.2007.02954.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Atrial Fibrillation in Patient With High Thrombotic Risk: Which Therapy?

AboutOpen
2018English

Monitoring of Serum Digoxin Concentration and Safety of Therapy With Digoxin in Patients With Atrial Fibrillation

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2018English

Anticoagulation in Patients With Atrial Fibrillation. Underuse of Warfarin Is Multifactorial.

BMJ
1993English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Comparison of Effects of Digoxin, Propranolol and Verapamil on Heart Rate Regulation in Patients With Chronic Atrial Fibrillation.

Japanese Journal of Electrocardiology
1986English

The Association Between Mean Platelet Volume and Chronic Atrial Fibrillation and the Presence of Thrombotic Events

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2015English

Left Atrial Strain Predicts Pro-Thrombotic State in Patients With Non-Valvular Atrial Fibrillation

Journal of Atrial Fibrillation
Cardiovascular MedicineCardiology
2017English

Pacing Therapy for Atrial Fibrillation

Journal of Nippon Medical School
Medicine
2001English

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy